GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Price-to-Free-Cash-Flow

Xiangxue Pharmaceutical Co (SZSE:300147) Price-to-Free-Cash-Flow : 14.67 (As of May. 29, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Price-to-Free-Cash-Flow?

As of today (2024-05-29), Xiangxue Pharmaceutical Co's share price is ¥3.58. Xiangxue Pharmaceutical Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.24. Hence, Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow Ratio for today is 14.67.

The historical rank and industry rank for Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow or its related term are showing as below:

SZSE:300147' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.88   Med: 34.82   Max: 499.41
Current: 14.6

During the past 13 years, Xiangxue Pharmaceutical Co's highest Price-to-Free-Cash-Flow Ratio was 499.41. The lowest was 10.88. And the median was 34.82.

SZSE:300147's Price-to-Free-Cash-Flow is ranked better than
77.14% of 210 companies
in the Biotechnology industry
Industry Median: 30.36 vs SZSE:300147: 14.60

Xiangxue Pharmaceutical Co's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥0.24.

During the past 13 years, Xiangxue Pharmaceutical Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 38.50% per year. The lowest was -208.30% per year. And the median was 16.70% per year.


Xiangxue Pharmaceutical Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co Price-to-Free-Cash-Flow Chart

Xiangxue Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 16.35

Xiangxue Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 181.72 90.00 16.35 18.07

Competitive Comparison of Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow falls into.



Xiangxue Pharmaceutical Co Price-to-Free-Cash-Flow Calculation

Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=3.58/0.244
=14.67

Xiangxue Pharmaceutical Co's Share Price of today is ¥3.58.
Xiangxue Pharmaceutical Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.24.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Xiangxue Pharmaceutical Co  (SZSE:300147) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Xiangxue Pharmaceutical Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Xiangxue Pharmaceutical Co (SZSE:300147) Business Description

Traded in Other Exchanges
N/A
Address
No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663
Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.
Executives
Huang Wei Hua Supervisors
Tan Wen Hui Director
Kang Zhi Ying Executives
Ceng Lun Executives
Liu Yan Executives
Lu Feng Executives
Xu Li Secretary, Director
Mo Zi Yu Supervisors
Mai Zhen Jiang Supervisors
Wang Yong Hui Directors, executives
He Tao Executives
Fang Wei Min Supervisors
Huang Bin Directors, Directors, and Executives
Wu Jun Executives
Chen Wen Jin Executives

Xiangxue Pharmaceutical Co (SZSE:300147) Headlines

No Headlines